Main Session
Sep
29
SS 35 - SBRT for Pancreaticobiliary Cancer, a SOFT Hand or a Lethal Blow?
293 - Primary and Retrospective Analysis of GRECO-2: A Randomized, Double-Blind, Placebo-Controlled Phase II Trial of SABR ± Rucosopasem in Localized Pancreatic Cancer
Presenter(s)
Todd Aguilera, MD, PhD - UT Southwestern Medical Center, Dallas, TX